Location: Cambridge, MA
ReviveMed is a pioneer at the intersection of artificial intelligence and metabolomics, Located in the heart of biotech innovation in Cambridge. Metabolomics is the large-scale study of small molecules, or metabolite, like glucose or cholesterol produced by the cellular activity. Metabolites are the closest link between cellular activity and what is observed in disease symptoms. ReviveMed uniquely overcomes the difficulties of identifying a large set of metabolites for each patient, based on technology developed at the Fraenkel Lab at MIT and published in Nature Methods. It further translates metabolomic data into novel therapeutic insights for drug and drug response biomarker discovery. Currently, ReviveMed is collaborating with tier-one pharmaceutical companies to support their drug discovery programs and in pursuing internal drug discovery, initially focused on fatty liver diseases.
ReviveMed is a seed-stage funded and award-winning startup company. Our oversubscribed seed round of $1.5 million was featured in TechCrunch. We are the recipients of many prestigious awards, including two LabCentral Golden Ticket awards from Novartis and Bristol-Myers Squibb, as well as the gold winner of the most innovative company of the year at the 2018 Stevie Awards for women in businesses.
We are an enthusiastic team, passionate about innovative, data-driven approaches to bring the right therapeutics for the right patients, and ultimately save millions of lives. We have a fast-paced, high-performance, and result-oriented culture, looking for candidates hungry for learning. The preferred candidate will bring relevant experience, entrepreneurial drive, and a passion for advancing our vision.